Skip to content

Medical-device intelligence

JWY: Manual Antimicrobial Susceptibility Test Systems

FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JWY
FDA device name
Manual Antimicrobial Susceptibility Test Systems
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202620
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JWY · Manual Antimicrobial Susceptibility Test Systems44178

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

519 matching records
Device / recordCompany in FDA recordSourceSource date
MTS Ampicillin-Sulbactam 0.016/0.008 - 256/128 µg/mLK192345 · JWYLiofilchem s.r.l.510(k)Oct 31, 2019FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Imipenem-Relebactam in the dilution range of 0.03/4-256/4 ug/mLK192250 · JWYThermo Fisher Scientific510(k)Oct 16, 2019FDA decision date
ETEST Eravacycline (ERV) (0.002 – 32 µg/mL)K192050 · JWYBiomerieux S.A.510(k)Sep 27, 2019FDA decision date
MTS Imipenem 0.016-256 µg/mLK191908 · JWYLiofilchem s.r.l.510(k)Sep 4, 2019FDA decision date
MTS Imipenem-relebactam 0.002/4-32/4 µg/mLK191809 · JWYLiofilchem s.r.l.510(k)Aug 23, 2019FDA decision date
ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)K191953 · JWYBiomerieux S.A.510(k)Aug 22, 2019FDA decision date
MTS Doxycycline 0.016 - 256 µg/mLK190914 · JWYLiofilchem s.r.l.510(k)May 29, 2019FDA decision date
ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL)K190154 · JWYBiomerieux S.A.510(k)May 1, 2019FDA decision date
MicroScan Dried Gram Negative MIC/Combo Panels with Eravacycline (ERV) (0.016-32 ug/mL)K190109 · JWYBeckman Coulter, Inc.510(k)Apr 18, 2019FDA decision date
MTS Gentamicin 0.016 - 256 µg/mLK190252 · JWYLiofilchem s.r.l.510(k)Mar 22, 2019FDA decision date
MTS Ciprofloxacin 0.002 - 32 µg/mLK183527 · JWYLiofilchem s.r.l.510(k)Mar 19, 2019FDA decision date
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline in the dilution r…K183324 · JWYThermo Fisher Scientific510(k)Feb 15, 2019FDA decision date
ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL)K183031 · JWYBiomerieux S.A.510(k)Jan 11, 2019FDA decision date
MTS Tetracycline 0.016 - 256 ug/mLK183140 · JWYLiofilchem s.r.l.510(k)Jan 11, 2019FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.03-32ug/mlK183033 · JWYThermo Fisher Scientific510(k)Jan 4, 2019FDA decision date
MTS Levofloxacin 0.002 - 32 µg/mLK183115 · JWYLiofilchem s.r.l.510(k)Dec 20, 2018FDA decision date
MTS Omadacycline 0.002-32 µg/mLK182922 · JWYLiofilchem s.r.l.510(k)Dec 14, 2018FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Eravacycline in the dilution range of 0.008- 16 µg/mLK182797 · JWYThermo Fisher Scientific510(k)Nov 30, 2018FDA decision date
MTS Eravacycline 0.002 - 32 µg/mLK182557 · JWYLiofilchem s.r.l.510(k)Nov 2, 2018FDA decision date
BECKMAN COULTER MicroScan MICroSTREP Plus Panel, MicroScan Mueller-Hinton Broth with 3% lysed horse blood, Catalog Number 81015 MicroScan Muelle…Z-1804-2018 · JWYBeckman Coulter Inc.RecallOct 2, 2018FDA classification date
MTS Penicillin 0.002- 32 µg/mLK181889 · JWYLiofilchem s.r.l.510(k)Sep 13, 2018FDA decision date
Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mLK181946 · JWYThermo Fisher Scientific510(k)Aug 8, 2018FDA decision date
MTS Plazomicin 0.016-256 µg/mLK181708 · JWYLiofilchem s.r.l.510(k)Jul 31, 2018FDA decision date
ETEST Telavancin (TLA) (0.002-32 ug/mL)K180936 · JWYBiomerieux S.A.510(k)Jul 3, 2018FDA decision date
Liofilchem MIC Test Strip (MTS), Delafloxacin 0.002 - 32 ug/mLK180886 · JWYLiofilchem s.r.l.510(k)May 18, 2018FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗